Stay updated on AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added system revision v3.3.2 and removed revision v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T13:30:57.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The funding/operating-status banner was removed from the page. Core study details remain unchanged.
    Difference
    0.8%
    Check dated 2025-11-18T07:17:51.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    A new version (2022-10-17) updates the study's recruitment status to terminated due to enrollment difficulties and consideration of clinical guidelines. The record history lists the version and its changes.
    Difference
    0.1%
    Check dated 2025-11-03T21:25:45.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Summary: The page now displays a status/operational notice and a version upgrade to v3.2.0, replacing the prior v3.1.0. Key impact is to inform users about current operating status and where to check details.
    Difference
    13%
    Check dated 2025-10-06T06:55:26.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.3%
    Check dated 2025-09-29T03:35:50.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, signaling a new version. The 'Back to Top' link was removed as a minor UI change.
    Difference
    0.8%
    Check dated 2025-09-14T21:29:32.000Z thumbnail image

Stay in the know with updates to AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.